buspirone has been researched along with Affective Disorders in 4 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on the assumption that fibromyalgia is more strongly related to stress and anxiety than affective spectrum disorders, we hypothesized that compared to population controls, fibromyalgia patients should demonstrate an increased prolactin response (DA sensitivity) to buspirone challenge test, but no difference in hypothermic response or GH release (5HT sensitivity)." | 7.72 | Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. ( Aakvaag, A; Lund, A; Malt, EA; Olafsson, S; Ursin, H, 2003) |
| "Based on the assumption that fibromyalgia is more strongly related to stress and anxiety than affective spectrum disorders, we hypothesized that compared to population controls, fibromyalgia patients should demonstrate an increased prolactin response (DA sensitivity) to buspirone challenge test, but no difference in hypothermic response or GH release (5HT sensitivity)." | 3.72 | Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. ( Aakvaag, A; Lund, A; Malt, EA; Olafsson, S; Ursin, H, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jelen, P | 1 |
| Soltysik, S | 1 |
| Zagrodzka, J | 1 |
| Malt, EA | 1 |
| Olafsson, S | 1 |
| Aakvaag, A | 1 |
| Lund, A | 1 |
| Ursin, H | 1 |
| Phillips, KA | 1 |
| Sharma, A | 1 |
| Oyebode, F | 1 |
| Kendall, MJ | 1 |
| Jones, DA | 1 |
1 trial available for buspirone and Affective Disorders
| Article | Year |
|---|---|
An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder.
Topics: Adult; Buspirone; Female; Humans; Male; Middle Aged; Mood Disorders; Prognosis; Selective Serotonin | 1996 |
3 other studies available for buspirone and Affective Disorders
| Article | Year |
|---|---|
22-kHz ultrasonic vocalization in rats as an index of anxiety but not fear: behavioral and pharmacological modulation of affective state.
Topics: Animals; Anxiety; Behavior, Animal; Buspirone; Carbolines; Conditioning, Classical; Diagnosis, Diffe | 2003 |
Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls.
Topics: Anxiety; Body Temperature; Buspirone; Cell Count; Female; Fibromyalgia; Humans; Middle Aged; Mood Di | 2003 |
Recovery from chronic fatigue syndrome associated with changes in neuroendocrine function.
Topics: Buspirone; Diagnosis, Differential; Exercise Therapy; Fatigue Syndrome, Chronic; Female; Humans; Mid | 2001 |